The brain implant startup Paradromics is taking steps to prepare for its first in-human trial next year, and the company announced on Monday that it has launched its official
Paradromics' system will initially serve as an assistive communication device that can turn brain signals into outputs like text or synthesized speech. This means patients with severe paralysis could eventually use it to regain their ability to communicate.BCIs have been studied in academia for decades, and several other companies, including Elon Musk's Neuralink, have been developing their own systems.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
ソース: ForbesTech - 🏆 318. / 59 続きを読む »